Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Update

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a large decline in short interest in July. As of July 15th, there was short interest totaling 456 shares, a decline of 43.8% from the June 30th total of 812 shares. Based on an average daily trading volume, of 3,103 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the shares of the stock are sold short.

Institutional Trading of Innovator IBD Breakout Opportunities ETF

Several large investors have recently modified their holdings of the business. Comprehensive Wealth Management LLC raised its position in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after purchasing an additional 12,859 shares during the last quarter. Susquehanna International Group LLP lifted its stake in Innovator IBD Breakout Opportunities ETF by 42.6% in the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after buying an additional 7,817 shares in the last quarter. Finally, Osaic Holdings Inc. grew its holdings in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after buying an additional 597 shares during the last quarter.

Innovator IBD Breakout Opportunities ETF Stock Performance

NYSEARCA BOUT traded up $0.24 during trading hours on Thursday, reaching $46.23. The company’s stock had a trading volume of 248 shares, compared to its average volume of 4,031. The stock has a market cap of $16.18 million, a PE ratio of 28.69 and a beta of 1.03. Innovator IBD Breakout Opportunities ETF has a fifty-two week low of $35.05 and a fifty-two week high of $49.41. The company’s 50-day moving average is $47.01 and its two-hundred day moving average is $43.17.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.